SCHEMBL19080166

SCHEMBL19080166

c1ccc2c(c1)ccc1oc3c4ccc(-c5ccc(-c6c7ccccc7c(-c7ccc8c(c7)oc7ccccc78)c7ccccc67)cc5)cc4c4ccccc4c3c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HCRTR1 O43613 1/20 0.35
ABCG2 Q9UNQ0 4/20 0.34
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
AHR P35869 2/20 0.34
NPC1 O15118 3/20 0.34
PAX8 Q06710 2/20 0.34
RAB9A P51151 2/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1A2 P05177 1/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34
PLA2G2A P14555 1/20 0.33
PLA2G4A P47712 1/20 0.33
ALOX5 P09917 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079995 0.90 CYP1A1 (0.40) TDP1L3MBTL1ABCG2AHRNPC1
SCHEMBL19079953 0.89 ABCG2 (0.43) TDP1L3MBTL1ABCG2AHRNPC1
SCHEMBL19080041 0.87 CYP1A1 (0.41) TDP1ABCG2AHRNPC1PAX8
SCHEMBL19081570 0.87 CYP1A1 (0.40) TDP1L3MBTL1HCRTR1ABCG2AHR
SCHEMBL19081497 0.87 ABCG2 (0.43) TDP1L3MBTL1ABCG2MMP12MMP13
SCHEMBL19080106 0.87 CYP1A1 (0.41) TDP1L3MBTL1ABCG2AHRNPC1
SCHEMBL20127530 0.87 CYP1A1 (0.39) TDP1HCRTR1ABCG2MMP12MMP13
SCHEMBL19080167 0.86 MAPT (0.34) L3MBTL1HCRTR1MMP12MMP13AHR
SCHEMBL19080172 0.86 PLA2G2A (0.36) TDP1L3MBTL1ABCG2NPC1RAB9A
SCHEMBL20127589 0.86 TDP1 (0.44) TDP1L3MBTL1HCRTR1ABCG2MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 TDP1 2603/4885L3MBTL1 1565/4885HCRTR1 200/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 TDP1 2603/4885L3MBTL1 1565/4885HCRTR1 200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.